Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity. (Q52677878)
Jump to navigation
Jump to search
scientific article published in March 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity. |
scientific article published in March 2018 |
Statements
Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity. (English)
1 reference
Ulrike Garske-Román
1 reference
Mattias Sandström
1 reference
Katarzyna Fröss Baron
1 reference
Lars Lundin
1 reference
Per Hellman
1 reference
Staffan Welin
1 reference
Silvia Johansson
1 reference
Tanweera Khan
1 reference
Hans Lundqvist
1 reference
Barbro Eriksson
1 reference
Anders Sundin
1 reference
Dan Granberg
1 reference
1 March 2018
1 reference
45
1 reference
6
1 reference
970-988
1 reference
1 March 2018
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference